Novel drug delivery system produced by centrifugal technologies – composed to minimize adverse immune reactions and designed for optimised therapeutic effects

Informations projet

DECENT AID

N° de convention de subvention: 324275

Projet clôturé

Date de début 1 Avril 2013

Date de fin 31 Mars 2017

Financé au titre de

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Coût total € 1 492 545,10

Contribution de l’UE € 1 492 545,10

Coordonné par

ABNOBA GMBH
Germany